Lindbrook Capital »

Fs Global Cr Opportunitie Fda shares owned by Lindbrook Capital

Quarter-by-quarter ownership of Fs Global Cr Opportunitie Fda (FSCO) shares owned by Lindbrook Capital from 13F filings

Historical chart of Lindbrook Capital investment in Fs Global Cr Opportunitie Fda

Tip: Access up to 7 years of quarterly data

All positions including Fs Global Cr Opportunitie Fda held by Lindbrook Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fs Global Cr Opportunitie Fda by Lindbrook Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $620 98 6.34
2024-06-30 $165k 26k 6.37
2024-03-31 $107k 18k 5.93

More positions owned by Lindbrook Capital

Vanguard Total Stk Mkt Etf (VTI)
Vanguard Total Intl Stock Idex Etf Etf (VXUS)
Apple Stock (AAPL)
Golub Cap Bdc Cef (GBDC)
Spdr S&p 500 Etf Trust Etf (SPY)
Ishares Russell 1000 Growth Etf Etf (IWF)
Nvidia Corporation Stock (NVDA)
Microsoft Stock (MSFT)
Rpar Risk Parity Etf Etf (RPAR)
Ishares Russell 1000 Value Etf Etf (IWD)
Amazon.com Stock (AMZN)
Powershares Qqq Tr Etf (QQQ)
Vertex Pharmaceuticals In Stock (VRTX)
Broadcom Stock (AVGO)
Vanguard Growth Etf Etf (VUG)

View all positions for Lindbrook Capital

Top funds holding Fs Global Cr Opportunitie Fda

Commonwealth Equity Services
Cambridge Investment Research Advisors
Nomura Holdings
Thomas J. Herzfeld Advisors
Wagner Wealth Management
Cetera Investment Advisers
LPL Financial
Envestnet Asset Management
H D Vest Advisory Services
Vista Finance
Rockefeller Capital Management
Advisor Group Holdings
Ellis Investment Partners
Private Advisor
Kestra Advisory Services

View all funds holding Fs Global Cr Opportunitie Fda